Adents: Cloud Serialization and Traceability

Company collaborates with Microsoft to introduce Adents Prodigi, a Level 4 traceability product for the pharmaceutical industry.

Company collaborates with Microsoft to introduce Adents Prodigi, a Level 4 traceability product for the pharmaceutical industry.
Company collaborates with Microsoft to introduce Adents Prodigi, a Level 4 traceability product for the pharmaceutical industry.

Adents, a provider of versatile and easily deployable serialization and track-and-trace software solutions, in collaboration with Microsoft, will introduce to the U.S. market Adents Prodigi, a new Cloud serialization and traceability offering.

Adents Prodigi centrally manages regulatory requirements mandated in the pharmaceutical industry. It allows pharmaceutical companies and CMOs to take advantage of the massive amounts of data generated during the serialization and track-and-trace process.

In addition to allowing for compliance with incrementally complex regulations, Adents Prodigi opens up new horizons beyond regulatory compliance in terms of data analysis (including Microsoft Power BI), machine learning tools or additionnal capabilities through third-party solutions such as OEE Tracker and Supplier Portal developed by Supply Chain Wizard.

The jointly developed solution will be showcased at INTERPHEX NYC, March 21-23, during a special conference with experts and executives of the Microsoft Team scheduled for Wednesday, March 22 at 3 p.m.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?